40 results match your criteria: "University of Edinburgh MRC Centre for Reproductive Health[Affiliation]"
BJOG
May 2016
Mater Research Institute, The University of Queensland, Brisbane, Qld, Australia.
Background: Decreased fetal movement is associated with adverse pregnancy and birth outcomes; timely reporting and appropriate management may prevent stillbirth.
Objectives: Determine effects of interventions to enhance maternal awareness of decreased fetal movement.
Search Strategy: Cinahl, The Cochrane Library, EMBASE, MEDLINE, PsycINFO and SCOPUS databases; without limitation on language or publication year.
BMJ
November 2015
Tommy's Centre for Maternal and Fetal Health, University of Edinburgh MRC Centre for Reproductive Health, Queen's Medical Research Institute, Edinburgh, UK.
Int J Gynaecol Obstet
October 2015
Department of Anesthesia, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Child and Family Research Institute, University of British Columbia, Vancouver, BC, Canada.
While we believe that pre-eclampsia matters-because it remains a leading cause of maternal and perinatal morbidity and mortality worldwide-we are convinced that the time has come to look beyond single clinical entities (e.g. pre-eclampsia, postpartum hemorrhage, obstetric sepsis) and to look for an integrated approach that will provide evidence-based personalized care to women wherever they encounter the health system.
View Article and Find Full Text PDFObstet Gynecol
May 2015
Division of Women's Health, King's College London, Women's Health Academic Centre Kings Health Partners, St. Thomas' Hospital, the UCL Institute for Women's Health, the Parturition Research Group, and the Institute for Reproductive and Developmental Biology, Imperial College London, London, the University of Edinburgh MRC Centre for Reproductive Health, Queen's Medical Research Institute, Edinburgh, and West Middlesex University Hospital, Middlesex, United Kingdom; and the Division of Maternal-Fetal Medicine, Loma Linda University Medical Center, Loma Linda, California.
Objective: To evaluate the diagnostic accuracy of cervicovaginal fluid quantitative fetal fibronectin, measured by a bedside analyzer, to predict spontaneous preterm birth before 34 weeks of gestation.
Methods: We conducted a prospective masked observational cohort study of cervicovaginal fluid quantitative fetal fibronectin concentration in asymptomatic women at high risk of spontaneous preterm birth (n=1,448; 22-27 6/7 weeks of gestation) measured using a rapid bedside analyzer. The routine qualitative result (positive-negative) was made available to clinicians at the time of testing, but the quantitative result remained blinded until after delivery.
PLoS One
January 2016
Tommy's Centre for Maternal and Fetal Health, University of Edinburgh MRC Centre for Reproductive Health, The Queen's Medical Research Institute, Edinburgh, United Kingdom.
Objectives: To determine the long-term effects of in utero progesterone exposure in twin children.
Methods: This study evaluated the health and developmental outcomes of all surviving children born to mothers who participated in a double-blind, placebo-controlled trial of progesterone given for the prevention of preterm birth in twin pregnancies (STOPPIT, ISRCTN35782581). Follow-up was performed via record linkage and two parent-completed validated questionnaires, the Child Development Inventory and the Health Utilities Index.
Mol Ther
September 2014
The Roslin Institute and Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Easter Bush, Midlothian, UK.
We have produced an Fc conjugate of colony-stimulating factor (CSF) 1 with an improved circulating half-life. CSF1-Fc retained its macrophage growth-promoting activity, and did not induce proinflammatory cytokines in vitro. Treatment with CSF1-Fc did not produce adverse effects in mice or pigs.
View Article and Find Full Text PDFJAMA Pediatr
April 2014
University of Western Australia School of Women's and Infants' Health, Crawley, Western Australia, Australia.
Aims: Human papillomavirus (HPV) testing is more sensitive than cytology for detection of residual/recurrent cervical disease after lesion treatment. Several HPV test comparison studies have been performed within triage and screening populations, but data on their comparative performance in a test of cure context is lacking. This study aims to address this gap.
View Article and Find Full Text PDFJ Clin Virol
February 2014
Institute of Cancer Sciences, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.
Background: As HPV testing is used increasingly for cervical disease management, there is a demand to optimise the performance of HPV tests, particularly with respect to specificity.
Objectives: To compare the clinical performance of an HPV DNA and a RNA based test in women with cytological abnormalities. The influence of age and assay cut off on test performance was also assessed.
Cytopathology
October 2013
HPV Research Group, The Queen's Medical Research Institute, University of Edinburgh MRC Centre for Reproductive Health, Edinburgh, UK.
Greater understanding of the role played by human papillomavirus (HPV) in the causation of disease has led to the development of an increasing number of HPV tests with different characteristics. The bewildering choice facing healthcare professionals and providers is daunting. Clearly, HPV testing is no longer simply of research interest, but can provide information that can be used for individual patient management and at the population level for cervical screening and vaccine surveillance.
View Article and Find Full Text PDFVirology
October 2013
HPV Research Group, University of Edinburgh MRC Centre for Reproductive Health, The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, Scotland, UK. Electronic address:
Human papillomaviruses (HPVs) are ubiquitous, well adapted to their host and cleverly sequestered away from immune responses. HPV infections can be productive, subclinical or latent in both skin and mucosa. The causal association of HPV with cervical cancer, and increasingly with rising numbers of squamous cell carcinomas at other sites in both men and women, is increasingly recognised, while the morbidity of cutaneous HPV lesions, particularly in the immunosuppressed population is also significant.
View Article and Find Full Text PDFProstaglandins Leukot Essent Fatty Acids
September 2013
University of Edinburgh/MRC Centre for Reproductive Health, The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. Electronic address:
Objective: To investigate the effect of omega-3 PUFAs, eicosapentanoic acid (EPA) and docosohexanoic acid (DHA) on inflammatory cytokine production in the amnion.
Study Design: Amnion explants were obtained at elective caesarean sections and cultured in vitro with EPA and DHA. IL-8 and IL-6 secretion was determined by ELISA, the role of PPARγ was investigated using specific agonists and antagonists and activity of MMP assessed by gelatin zymography.
Obstet Gynecol
May 2013
University of Edinburgh MRC Centre for Reproductive Health, Queen's Medical Royal, the Infirmary of Edinburgh, Little France, the Simpson Centre for Reproductive Health, and the Neonatal Unit, Simpson Centre for Reproductive Health, Edinburgh, and Medway National Health Service Foundation Trust, Gillingham, Kent, United Kingdom.
Objective: To estimate the rates of early neonatal and maternal complications in a consecutive series of successful Kielland's rotational forceps deliveries.
Methods: This was a retrospective cohort study of consecutive cases of successful rotational forceps deliveries performed in singleton pregnancies at 36 weeks of gestation or more in a tertiary referral center in Scotland, UK, from 2001 to 2008 (n=873). We also compared outcomes associated with successful rotational forceps deliveries in 2008 (n=150) with those of nonrotational forceps delivery (n=873), ventouse delivery (n=159), spontaneous vertex delivery (n=3,494), and emergency cesarean delivery (n=947).
BMC Pregnancy Childbirth
August 2012
University of Edinburgh MRC Centre for Reproductive Health, The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TY, UK.
Background: Preterm birth is a global problem, with a prevalence of 8 to 12% depending on location. Several large trials and systematic reviews have shown progestogens to be effective in preventing or delaying preterm birth in selected high risk women with a singleton pregnancy (including those with a short cervix or previous preterm birth). Although an improvement in short term neonatal outcomes has been shown in some trials these have not consistently been confirmed in meta-analyses.
View Article and Find Full Text PDF